Accord Healthcare B.V. - rezultati iskanja

accord healthcare limited - zoledronic acid monohydrate - concentrate for solution for infusion - 4 mg/5 ml concentrate - hypercalcemia cancer, bone fractures - drug affecting bone structure and mineralization, bisphosphonates - prevention of skeletal related events (pathological fractures, spinal compression, radiation or surgery to bone, or tumour-induced hypercalcaemia) in adult patients with advanced malignancies involving bone. treatment of adult patients with tumour-induced hypercalcaemia (tih).

Evropska unija - angleščina - EMA (European Medicines Agency)

abiraterone accord

accord healthcare s.l.u. - abiraterone acetate - prostatic neoplasms - endocrine therapy - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Evropska unija - angleščina - EMA (European Medicines Agency)

cinacalcet accordpharma

accord healthcare s.l.u. - cinacalcet hydrochloride - hyperparathyroidism - calcium homeostasis - secondary hyperparathyroidismadultstreatment of secondary hyperparathyroidism (hpt) in adult patients with end-stage renal disease (esrd) on maintenance dialysis therapy.paediatric populationtreatment of secondary hyperparathyroidism (hpt) in children aged 3 years and older with end-stage renal disease (esrd) on maintenance dialysis therapy in whom secondary hpt is not adequately controlled with standard of care therapy (see section 4.4).cinacalcet accordpharma may be used as part of a therapeutic regimen including phosphate binders and/or vitamin d sterols, as appropriate (see section 5.1).parathyroid carcinoma and primary hyperparathyroidism in adultsreduction of hypercalcaemia in adult patients with:parathyroid carcinoma.primary hpt for whom parathyroidectomy would be indicated on the basis of serum calcium levels (as defined by relevant treatment guidelines), but in whom parathyroidectomy is not clinically appropriate or is contraindicated.